Loading...

The Scientist

» CAR T cells

Most Recent

image: World’s Largest Cell and Gene Therapy Plant Opens

World’s Largest Cell and Gene Therapy Plant Opens

By Catherine Offord | April 11, 2018

Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.

0 Comments

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 

0 Comments

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By Lucas Laursen | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By Katarina Zimmer | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

image: First CAR T-Cell Therapy Approved in U.S.

First CAR T-Cell Therapy Approved in U.S.

By Shawna Williams | August 30, 2017

The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.

1 Comment

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By Jef Akst | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

image: The Ever-Expanding T-Cell World: A Primer

The Ever-Expanding T-Cell World: A Primer

By Ashley P. Taylor | August 7, 2017

Researchers continue to identify new T-cell subtypes—and devise ways to use them to fight cancer. The Scientist attempts to catalog them all.

2 Comments

Popular Now

  1. Salk Institute Suspends Cancer Scientist Inder Verma
  2. Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide
  3. Jim Bridenstine Confirmed to Lead NASA
  4. RNA Injection Restores Hearing in Guinea Pigs